Rhumbline Advisers Acquires 3,130 Shares of Cullinan Therapeutics, Inc. (NASDAQ:CGEM)
Rhumbline Advisers boosted its position in Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Free Report) by 4.6% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 71,338 shares of the company’s stock after buying an additional 3,130 shares during the period. Rhumbline […]
Rhumbline Advisers boosted its position in Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Free Report) by 4.6% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 71,338 shares of the company’s stock after buying an additional 3,130 shares during the period. Rhumbline […]
